Contrast injector technology firm Medrad said that it has received U.S. Food and Drug Administration clearance for use of its Continuum MR infusion system in MR environments up to and including 3 tesla.
The Indianola, PA-based firm said its product underwent and passed testing for attraction, homogeneity, artifact, and static magnetic fields.
By AuntMinnie.com staff writers
June 8, 2006
Related Reading
Medrad hits Stellant milestone, May 5, 2006
Consorta offers group buys, March 22, 2006
Medrad revenues up, March 2, 2006
Medrad goes direct in Belgium, Luxembourg, January 16, 2006
Medrad signs Amerinet, December 20, 2005
Copyright © 2006 AuntMinnie.com